Role of STAT3 in Genesis and Progression of Human Malignant Gliomas

Abstract : Signal Transducer and Activator of Transcription 3 (STAT3) is aberrantly activated in glioblastoma and has been identified as a relevant therapeutic target in this disease and many other human cancers. After two decades of intensive research, there is not yet any approved STAT3-based glioma therapy. In addition to the canonical activation by tyrosine 705 phosphorylation, concordant reports described a potential therapeutic relevance of other post-translational modifications including mainly serine 727 phosphorylation. Such reports reinforce the need to refine the strategy of targeting STAT3 in each concerned disease. This review focuses on the role of serine 727 and tyrosine 705 phosphorylation of STAT3 in glioma. It explores their contribution to glial cell transformation and to the mechanisms that make glioma escape to both immune control and standard treatment.
Complete list of metadatas

Cited literature [217 references]  Display  Hide  Download
Contributor : Emmanuel Chautard <>
Submitted on : Friday, November 17, 2017 - 10:11:28 AM
Last modification on : Tuesday, April 2, 2019 - 11:34:08 AM
Long-term archiving on : Sunday, February 18, 2018 - 1:26:17 PM


mol neurobiol_POST PRINT.pdf
Files produced by the author(s)




Zangbewende Guy Ouedraogo, Julian Biau, Jean-Louis Kemeny, Laurent Morel, Pierre Verrelle, et al.. Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. Molecular Neurobiology, Humana Press, 2017, 54 (8), pp.5780-5797. ⟨10.1007/s12035-016-0103-0⟩. ⟨hal-01636877⟩



Record views


Files downloads